Accessibility Menu
 
Fresenius SE & Co logo

Fresenius SE & Co

(OTC) FSNUY

Current Price$12.96
Market Cap$29.20B
Since IPO (2011)+98%
5 Year+24%
1 Year+19%
1 Month-4%

Fresenius SE & Co Financials at a Glance

Market Cap

$29.20B

Revenue (TTM)

$22.80B

Net Income (TTM)

$1.26B

EPS (TTM)

$0.64

P/E Ratio

20.32

Dividend

$0.28

Beta (Volatility)

0.56 (Low)

Price

$12.96

Volume

42,501

Open

$13.30

Previous Close

$12.96

Daily Range

$12.85 - $13.30

52-Week Range

$10.96 - $33.93

FSNUY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius SE & Co

Industry

Healthcare Providers and Services

Employees

178,394

CEO

Michael Sen, MBA

Headquarters

Bad Homburg vor der Höhe, 61352, DE

FSNUY Financials

Key Financial Metrics (TTM)

Gross Margin

25%

Operating Margin

10%

Net Income Margin

6%

Return on Equity

8%

Return on Capital

7%

Return on Assets

3%

Earnings Yield

4.92%

Dividend Yield

0.02%

Payout Ratio

61.47%

Stock Overview

Market Cap

$29.20B

Shares Outstanding

2.25B

Volume

42.50K

Short Interest

0.00%

Avg. Volume

71.07K

Financials (TTM)

Gross Profit

$5.47B

Operating Income

$2.09B

EBITDA

$3.17B

Operating Cash Flow

$2.59B

Capital Expenditure

$1.44B

Free Cash Flow

$1.15B

Cash & ST Invst.

$1.58B

Total Debt

$11.93B

Fresenius SE & Co Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$6.10B

+8.3%

Gross Profit

$1.51B

+6.7%

Gross Margin

24.76%

N/A

Market Cap

$29.20B

N/A

Market Cap/Employee

$166.65K

N/A

Employees

175,202

N/A

Net Income

$357.61M

+49.0%

EBITDA

$836.09M

-11.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.34B

+10.3%

Accounts Receivable

$5.80B

+11.7%

Inventory

$2.61B

+1.4%

Long Term Debt

$10.46B

-3.2%

Short Term Debt

$1.47B

-47.0%

Return on Assets

3.05%

N/A

Return on Invested Capital

6.59%

N/A

Free Cash Flow

$599.85M

-9.4%

Operating Cash Flow

$1.30B

+36.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SMMNYSiemens Healthineers AG
$22.48-0.31%
FMCQFFresenius Medical Care AG & Co. KGaA
$44.25-10.08%
CSLLYCSL Limited
$24.67-2.85%
ESLOYEssilorLuxottica S.A.
$121.53+0.85%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07-0.02%
QBTSD-Wave Quantum
$21.52+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$56.43+0.01%
HIMSHims & Hers Health
$26.99+0.11%

Questions About FSNUY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.